Overview
- Nelson’s identical twin daughters, Ocean and Story, were diagnosed with Spinal Muscular Atrophy Type 1 in January 2026 and face intensive daily care and long‑term disability risks.
- She says planned gene‑therapy treatment was delayed after one twin was hospitalised with pneumonia and the other became unwell, which she fears may cause irreversible nerve and muscle damage.
- Nelson launched a high‑profile campaign and petition that prompted a parliamentary debate and she uses Jesy Nelson: Life Changing, released on Friday, to press for change.
- Health officials have recommended a staggered introduction of newborn SMA screening starting in October 2026 that will initially cover about 72 percent of England, leaving some major areas without immediate access.
- The newborn test is a heel‑prick blood‑spot taken days after birth and can identify SMA early so clinicians can give time‑sensitive gene treatment, a point campaigners say makes nationwide screening urgent.